Drug Company Bonanza

New guidelines issued that recommend lower than ever LDL (bad cholesterol) levels could prove to be a goldmine for those drug companies that produce the drugs that help to lower those levels. Newsday reports that many of the physicians that sit on the panel that issued the guidelines that recommended the changes have a financial relationship with these same drug companies.